Literature DB >> 19030005

Consensus practice guidelines for bisphosphonate-associated osteonecrosis of the jaw.

Philip N Sambrook1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19030005     DOI： 10.1038/ncprheum0960

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN： 1745-8382


× No keyword cloud information.
  9 in total

1.  Bisphosphonates and avascular necrosis of the jaws.

Authors:  G D Carter; Alastair N Goss
Journal:  Aust Dent J       Date:  2003-12       Impact factor: 2.291

2.  Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.

Authors:  Dennis M Black; Ann V Schwartz; Kristine E Ensrud; Jane A Cauley; Silvina Levis; Sara A Quandt; Suzanne Satterfield; Robert B Wallace; Douglas C Bauer; Lisa Palermo; Lois E Wehren; Antonio Lombardi; Arthur C Santora; Steven R Cummings
Journal:  JAMA       Date:  2006-12-27       Impact factor: 56.272

3.  Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

Authors:  Tony Mavrokokki; Andrew Cheng; Brien Stein; Alastair Goss
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

4.  Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

Authors:  Robert E Marx
Journal:  J Oral Maxillofac Surg       Date:  2003-09       Impact factor: 1.895

5.  Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.

Authors:  N Yarom; R Yahalom; Y Shoshani; W Hamed; E Regev; S Elad
Journal:  Osteoporos Int       Date:  2007-06-28       Impact factor: 4.507

6.  Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.

Authors:  Aliya A Khan; George K B Sándor; Edward Dore; Archibald D Morrison; Mazen Alsahli; Faizan Amin; Edmund Peters; David A Hanley; Sultan R Chaudry; David W Dempster; Francis H Glorieux; Alan J Neville; Reena M Talwar; Cameron M Clokie; Majd Al Mardini; Terri Paul; Sundeep Khosla; Robert G Josse; Susan Sutherland; David K Lam; Robert P Carmichael; Nick Blanas; David Kendler; Steven Petak; Louis Georges St-Marie; Jacques Brown; A Wayne Evans; Lorena Rios; Juliet E Compston
Journal:  J Rheumatol       Date:  2008-06-01       Impact factor: 4.666

7.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

8.  Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.

Authors:  Salvatore L Ruggiero; Bhoomi Mehrotra; Tracey J Rosenberg; Stephen L Engroff
Journal:  J Oral Maxillofac Surg       Date:  2004-05       Impact factor: 1.895

9.  The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

Authors:  J Jaime Caro; Khajak J Ishak; Krista F Huybrechts; Gabriel Raggio; Christel Naujoks
Journal:  Osteoporos Int       Date:  2004-05-27       Impact factor: 4.507
  9 in total
  1 in total

1.  The Role of Semipurified Fractions Isolated from Quercus infectoria on Bone Metabolism by Using hFOB 1.19 Human Fetal Osteoblast Cell Model.

Authors:  Amira Raudhah Abdullah; Hermizi Hapidin; Hasmah Abdullah
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-13       Impact factor: 2.629
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.